Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseobservationalRules rewrite

3D Modeling of Deep Endometriosis From Pelvic MRI

This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management.

Official registry: https://clinicaltrials.gov/study/NCT07864883 · University Hospital, Strasbourg, France · enrollment listed as 60

What this phase means

This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.

They plan to enroll about 60 people at Strasbourg. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Three-Dimensional Modeling of Deep Endometriosis From Pelvic MRI

Primary outcome (registry wording): Impact of 3D modeling on surgical planning

Who it is for (from inclusion criteria)

  • Ages 18 Years to any
  • Women only
  • Patient aged 18 years or older
  • Confirmed diagnosis of deep endometriosis
  • Available and interpretable preoperative pelvic MRI
  • Surgical management performed at Strasbourg University Hospital between 01/01/2020 and 12/31/2022
  • No documented opposition to reuse of medical data

Public study contact (from the registry)

Lise Lecointre, MD, PhD

33 3 88 12 74 72

lise.lecointre@chru-strasbourg.fr

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseScottsdale, Arizona
Not a traditional drug phase: Quality-of-Life Assessment for Cervical Carcinoma

This early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after surgery for the treatment of endometrial or cervical cancer. Radiation therapy uses high energy protons or x-rays to kill tumor cells and shrink tumors.

NCT04567771 · Official ClinicalTrials.gov record · Mayo Clinic

RecruitingNot a traditional drug phaseChandler, Arizona
Not a traditional drug phase: Observational study, no intervention for Endometriosis

The goal of this watch-and-measure (no experimental treatment required) study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test

NCT05245695 · Official ClinicalTrials.gov record · Aspira Women's Health

FAQ about this NCT record

Is NCT07864883 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07864883?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07864883?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary